Published in Biomed Res Int on July 14, 2014
FK 506 for liver, kidney, and pancreas transplantation. Lancet (1989) 13.70
Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet (1979) 6.10
Tacrolimus: a further update of its use in the management of organ transplantation. Drugs (2003) 1.72
Race and electronically measured adherence to immunosuppressive medications after deceased donor renal transplantation. J Am Soc Nephrol (2005) 1.54
Adherence to medication after liver transplantation in Scotland: a pilot study. Liver Transpl (2006) 1.51
Once- versus twice-daily tacrolimus: are the formulations truly equivalent? Drugs (2011) 1.10
Noncompliance in organ transplant recipients: a literature review. Gen Hosp Psychiatry (2000) 1.07
Immunosuppression and modulation in liver transplantation. Nephrol Dial Transplant (2004) 1.03
De novo kidney transplant recipients need higher doses of Advagraf compared with Prograf to get therapeutic levels. Transplant Proc (2009) 1.01
First clinical experience with the new once-daily formulation of tacrolimus. Ther Drug Monit (2008) 0.97
Lower variability of tacrolimus trough concentration after conversion from prograf to advagraf in stable kidney transplant recipients. Transplantation (2011) 0.93
Adherence in liver transplant recipients. Liver Transpl (2011) 0.92
Forty years of publication of transplantation proceedings--the second decade: the cyclosporine revolution. Transplant Proc (2009) 0.91
Once daily tacrolimus formulation: monitoring of plasma levels, graft function, and cardiovascular risk factors. Transplant Proc (2010) 0.91
Late hepatic allograft dysfunction. Liver Transpl (2001) 0.90
Tacrolimus once-daily formulation: in the prophylaxis of transplant rejection in renal or liver allograft recipients. Drugs (2007) 0.87
Postoperative flow cytometry crossmatch in living donor liver transplantation: clinical significance of humoral immunity in acute rejection. Transplantation (1999) 0.87
Role of tacrolimus in the evolution of liver transplantation. Transplantation (2004) 0.87
Safety of conversion from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in stable liver transplant recipients. Transplant Proc (2010) 0.83
Impact of the conversion of the immunosuppressive regimen from prograf to advagraf or to sirolimus in long-term stable liver transplant recipients: indications, safety, and outcome. Transplant Proc (2011) 0.81
Effect of Prophylactic Antifungal Protocols on the Prognosis of Liver Transplantation: A Propensity Score Matching and Multistate Model Approach. Biomed Res Int (2016) 0.75
Efficacy of External Beam Radiation-Based Treatment plus Locoregional Therapy for Hepatocellular Carcinoma Associated with Portal Vein Tumor Thrombosis. Biomed Res Int (2016) 0.75
Renal Function Improvement by Telbivudine in Liver Transplant Recipients with Chronic Kidney Disease. Biomed Res Int (2017) 0.75